FIFTH CONFERENCE ON DNA TOPOISOMERASES IN THERAPY

我们建议举办“第五届DNA拓扑异构酶会议， 1994年10月3日至6日，在纽约大学医学中心举行。编制和 会议的组织工作将包括： 具体目标#1。通过邮件和 在科学期刊上刊登广告或公告。 具体目标#2会议的组织工作， 为期三天半的会议，包括七次幻灯片全体会议 演讲，并与三个海报讨论会。滑动 会议将包括特邀发言人，其中大多数是 该领域，和选定的提供论文的主持人。有三 全体会议将讨论的主要专题领域： (i)原核和真核拓扑异构酶的基础研究 和新的进展。 (ii)喹诺酮类及相关化合物，DNA促旋酶抑制剂， 感染的治疗。 (iii)新的抗癌剂，DNA拓扑异构酶I和II的抑制剂， 实验室、临床前和临床研究。 具体目标#3会议摘要将印在小册子上， 在会议上提供，并随后通过邮件分发给感兴趣的 investigators.与以往一样，会议主题的出版物作为完整的- 会议结束后，演讲者在参考期刊上发表了大量文章。 将设法将选定的专题作为会议出版物出版， 诉讼

We propose to organize the "Fifth Conference on DNA Topoisomerases in Therapy" on October 3 through 6, 1994, at NYUMC. The preparation and organization of the Conference will include: Specific Aim #1. Dissemination of conference information by mail and by advertisement or announcements in scientific journals. Specific Aim #2. Organization of the conference, which will be held as a three-and-half day meeting, with seven plenary sessions of slide presentations, and with three poster-discussion sessions. The slide sessions will include invited speakers, most of them leading experts in the field, and presenters of selected proffered papers. There are three major topic areas to be covered in plenary sessions: (i) Basic research of prokaryotic and eukaryotic topoisomerases, overview and new advances. (ii) Quinolones and related compounds, inhibitors of DNA gyrase, in therapy of infection. (iii) New anticancer agents, inhibitors of DNA topoisomerase l and Il, in laboratory, preclinical and clinical research. Specific Aim #3. Conference abstracts, printed in a brochure, will be available at the meeting and, later on, distributed by mail to interested investigators. As in the past, publications of Conference topics as full- size articles by the speakers in refereed journals follows the conference. An attempt will be made to publish selected topics as Conference proceedings.